Drug Type Small molecule drug |
Synonyms (6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Cefoperazone, Cefoperazone sodium (JP17/USP) + [15] |
Target |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (18 Nov 1982), |
Regulation- |
Molecular FormulaC25H27N9O8S2 |
InChIKeyGCFBRXLSHGKWDP-XCGNWRKASA-N |
CAS Registry62893-19-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00918 | Cefoperazone Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bacterial Infections | CN | 01 Jan 1989 |